INCB001158 Uses, Dosage, Side Effects and more
INCB001158 is under investigation in clinical trial NCT03910530 (A Study of INCMGA00012, INCB001158, and the Combination in Japanese Participants With Advanced Solid Tumors).
| Trade Name | INCB001158 |
| Generic | CB-1158 |
| CB-1158 Other Names | INCB001158 |
| Type | |
| Formula | C11H22BN3O5 |
| Weight | Average: 287.12 Monoisotopic: 287.165251 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
